Indeed, in a recent work aimed at elucidating the anticancer effects of the NF-kB inhibitor BAY 11-7085 (BAY), this compound was found to induce ferroptosis in human cancer cell lines of different origin, which was NF-kB independent but largely dependent on iron overload and altered redox homeostasis. This evidence concerns the gene NFKB1 and cancer.